What is the recommended evaluation and management for seminal vasculitis in a male patient presenting with scrotal or pelvic pain, ejaculatory discomfort, and possible infertility?

Seminal Vasculitis: Evaluation and Management

Seminal vasculitis is an exceedingly rare entity that typically presents as an incidental histologic finding rather than a primary clinical diagnosis, and when suspected based on scrotal or pelvic pain, requires systematic exclusion of more common chronic pelvic pain etiologies before consideration of vasculitis-specific workup.

Clinical Context and Diagnostic Approach

Seminal vasculitis exists in two distinct clinical scenarios that require different management approaches:

Isolated Seminal Vesicle Vasculitis

This is predominantly an incidental pathologic finding discovered in surgical specimens (typically radical prostatectomy), where necrotizing vasculitis is confined to seminal vesicles without systemic disease 1. These patients are generally asymptomatic, though local findings like dense adhesions may occur 1. The key management principle is careful clinical follow-up to exclude subsequent development of systemic vasculitis 1.

Scrotal Vasculitis as Part of Systemic Disease

When vasculitis affects the scrotal contents (vas deferens, epididymis), it typically represents manifestation of systemic vasculitides like polyarteritis nodosa or Schönlein-Henoch syndrome 2, 3. This can mimic acute epididymitis or testicular torsion 2.

Recommended Evaluation Algorithm

Since true seminal vasculitis is rare, your evaluation should follow the 2025 AUA Chronic Pelvic Pain Guidelines framework 4:

Initial Assessment (All Patients)

• Comprehensive pain characterization: Document onset circumstances, duration (>3 months for chronic), location, quality, exacerbating/relieving factors 4
• Associated genitourinary symptoms: Ejaculatory discomfort, bladder storage/voiding symptoms, erectile dysfunction 4
• Psychosocial screening: Anxiety, depression, major life stressors, impact on quality of life and daily functioning 4
• Prior treatments and outcomes: Previous surgeries, medications, interventions 4

Physical Examination Specifics

The examination must identify reproducible tenderness patterns 4, 5:

• Testicular tenderness (present in 45% of chronic scrotal pain) 5
• Epididymal tenderness (55% of cases) 5
• Spermatic cord tenderness (28% of cases) 5
• Pelvic floor myalgia: Standardized abdominal and pelvic examination for musculoskeletal pain sources 4
• Neurological, musculoskeletal, orthopedic abnormalities of pelvis and hip 4

Critical caveat: 33% of chronic scrotal pain patients have no reproducible scrotal tenderness, suggesting referred pain from musculoskeletal or other sources 5. This makes alternative diagnoses essential to consider.

Laboratory and Imaging Studies

• Urinalysis and mid-stream urine culture (mandatory baseline) 4
• Post-void residual volume via bladder scanner 4
• Scrotal ultrasound: To exclude testicular torsion, epididymitis, orchitis, abscess, testicular mass, varicocele 4
• MRI pelvis: If seminal vesicle pathology suspected (can identify cystic lesions, anatomic abnormalities) 6
• CT imaging: May reveal seminal vesicle fluid collections in acute vasitis 7

Vasculitis-Specific Workup (When Indicated)

Consider systemic vasculitis evaluation if:

• Constitutional symptoms present (fever, weight loss, malaise)
• Multi-organ involvement suggested
• Skin manifestations (palpable purpura, livedo reticularis)
• Renal dysfunction or hematuria

This requires:

• Complete blood count, inflammatory markers (ESR, CRP)
• Comprehensive metabolic panel with renal function
• Vasculitis serologies (ANCA, complement levels, cryoglobulins)
• Tissue biopsy for definitive diagnosis (may require surgical exploration) 2
• Five Factor Score if polyarteritis nodosa suspected (provides prognostic information before initiating immunosuppression) 3

Management Framework

For Suspected Isolated Seminal Vasculitis

Since this is typically an incidental finding 1:

• Surveillance approach: Serial clinical evaluations to monitor for systemic vasculitis development
• Symptom management: If local symptoms present, treat as chronic pelvic pain (see below)
• Avoid unnecessary surgery: Imaging can prevent surgical intervention 7

For Chronic Pelvic/Scrotal Pain (Most Common Scenario)

Follow the multimodal approach outlined in 2025 AUA guidelines 4, 8:

First-line interventions:

• Lifestyle modifications: Dietary changes (avoid spicy foods, coffee, tea, chili, alcohol; increase fruits/vegetables, water, fiber) 8
• Aerobic exercise 8
• Pelvic floor physical therapy: Essential for pelvic floor myalgia, which co-exists in many chronic pelvic pain conditions 4

Pharmacologic options (all off-label for CP/CPPS) 8:

• NSAIDs for symptomatic relief 6
• Antibiotics if infection suspected (though evidence for fertility improvement exists, natural conception rates don't clearly improve) 9
• Alpha-blockers, muscle relaxants, neuropathic pain medications (based on phenotype)

Referral considerations:

• Musculoskeletal evaluation: 39% of chronic scrotal pain has musculoskeletal etiology 5
• Rheumatology: If systemic vasculitis confirmed
• Pain management/psychology: For refractory cases with significant psychosocial impact 4

For Confirmed Systemic Vasculitis

• Corticosteroids and/or cyclophosphamide: Standard immunosuppressive therapy 3
• Fertility preservation counseling: Before cyclophosphamide therapy 10
• Multidisciplinary management: Rheumatology-led care with urology consultation

Critical Pitfalls to Avoid

1. Don't assume scrotal pain equals scrotal pathology: One-third have no local findings; consider referred pain from spine, hip, abdomen 5
2. Don't rush to surgery: 24% of chronic scrotal pain patients had prior unsuccessful surgical intervention 5; imaging and conservative management should be exhausted first 7
3. Don't miss systemic vasculitis: Testicular pain may be the first or main symptom of polyarteritis nodosa 3; always search for systemic spread before initiating local treatment
4. Don't overlook psychosocial factors: Build therapeutic rapport by acknowledging pain validity and actively listening to quality of life impact 4
5. Don't forget fertility implications: If vasculitis confirmed and immunosuppression needed, discuss fertility preservation options before cyclophosphamide 10

Clinical Reality Check

In practical terms, a patient presenting with "seminal vasculitis" symptoms will almost certainly have chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) or chronic scrotal content pain (CSCP) rather than true vasculitis 4. The 2025 AUA guidelines provide the evidence-based framework for these common conditions 4, 8. True seminal vasculitis remains a rare histologic diagnosis requiring vigilance for systemic disease evolution 1.